Identifying radiation-induced survivorship syndromes affecting bowel health in a cohort of gynecological cancer survivors
Gunnar Steineck, Viktor Skokic, Fei Sjöberg, Cecilia Bull, Eleftheria Alevronta, Gail Dunberger, Karin Bergmark, Ulrica Wilderäng, Jung Hun Oh, Joseph O Deasy, Rebecka Jörnsten, Gunnar Steineck, Viktor Skokic, Fei Sjöberg, Cecilia Bull, Eleftheria Alevronta, Gail Dunberger, Karin Bergmark, Ulrica Wilderäng, Jung Hun Oh, Joseph O Deasy, Rebecka Jörnsten
Abstract
Background: During radiotherapy unwanted radiation to normal tissue surrounding the tumor triggers survivorship diseases; we lack a nosology for radiation-induced survivorship diseases that decrease bowel health and we do not know which symptoms are related to which diseases.
Methods: Gynecological-cancer survivors were followed-up two to 15 years after having undergone radiotherapy; they reported in a postal questionnaire the frequency of 28 different symptoms related to bowel health. Population-based controls gave the same information. With a modified factor analysis, we determined the optimal number of factors, factor loadings for each symptom, factor-specific factor-loading cutoffs and factor scores.
Results: Altogether data from 623 survivors and 344 population-based controls were analyzed. Six factors best explain the correlation structure of the symptoms; for five of these a statistically significant difference (P< 0.001, Mann-Whitney U test) was found between survivors and controls concerning factor score quantiles. Taken together these five factors explain 42 percent of the variance of the symptoms. We interpreted these five factors as radiation-induced syndromes that may reflect distinct survivorship diseases. We obtained the following frequencies, defined as survivors having a factor loading above the 95 percent percentile of the controls, urgency syndrome (190 of 623, 30 percent), leakage syndrome (164 of 623, 26 percent), excessive gas discharge (93 of 623, 15 percent), excessive mucus discharge (102 of 623, 16 percent) and blood discharge (63 of 623, 10 percent).
Conclusion: Late effects of radiotherapy include five syndromes affecting bowel health; studying them and identifying the underlying survivorship diseases, instead of the approximately 30 long-term symptoms they produce, will simplify the search for prevention, alleviation and elimination.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- Steineck G, Schmidt H, Alevronta E, Sjoberg F, Bull CM, Vordermark D. Toward Restored Bowel Health in Rectal Cancer Survivors. Seminars in radiation oncology. 2016;26(3):236–50.
- Jackson A, Marks LB, Bentzen SM, Eisbruch A, Yorke ED, Ten Haken RK, et al. The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S155–60. 10.1016/j.ijrobp.2009.08.074
- Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S123–9. 10.1016/j.ijrobp.2009.03.078
- Andreyev HJ. Pelvic radiation disease. Colorectal Dis. 2015;17(1):2–6. 10.1111/codi.12812
- Andreyev HJ, Muls AC, Norton C, Ralph C, Watson L, Shaw C, et al. Guidance: The practical management of the gastrointestinal symptoms of pelvic radiation disease. Frontline Gastroenterol. 2015;6(1):53–72. 10.1136/flgastro-2014-100468
- Teo MT, Sebag-Montefiore D, Donnellan CF. Prevention and Management of Radiation-induced Late Gastrointestinal Toxicity. Clin Oncol (R Coll Radiol). 2015;27(11):656–67.
- Gilman A. The initial clinical trial of nitrogen mustard. Am J Surg. 1963;105:574–8.
- Goodman LS, Wintrobe MM, et al. Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. Journal of the American Medical Association. 1946;132:126–32.
- Yamauchi FI, Penzkofer T, Fedorov A, Fennessy FM, Chu R, Maier SE, et al. Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRI sequence. Magn Reson Imaging. 2015;33(5):525–30. 10.1016/j.mri.2015.02.006
- Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. The New England journal of medicine. 1999;340(18):1383–9. 10.1056/NEJM199905063401802
- Kreicbergs U, Valdimarsdottir U, Onelov E, Henter JI, Steineck G. Talking about death with children who have severe malignant disease. The New England journal of medicine. 2004;351(12):1175–86. 10.1056/NEJMoa040366
- Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlen BJ, et al. Quality of life after radical prostatectomy or watchful waiting. The New England journal of medicine. 2002;347(11):790–6. 10.1056/NEJMoa021483
- Steineck G, Bergmark K, Henningsohn L, al-Abany M, Dickman PW, Helgason A. Symptom documentation in cancer survivors as a basis for therapy modifications. Acta Oncol. 2002;41(3):244–52.
- Dunberger G, Lind H, Steineck G, Waldenstrom AC, Nyberg T, Al-Abany M, et al. Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls. European journal of cancer. 2010;46(3):606–15. 10.1016/j.ejca.2009.10.023
- Dunberger G, Lind H, Steineck G, Waldenstrom AC, Nyberg T, al-Abany M, et al. Fecal incontinence affecting quality of life and social functioning among long-term gynecological cancer survivors. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society. 2010;20(3):449–60.
- Dunberger G, Lind H, Steineck G, Waldenstrom AC, Onelov E, Avall-Lundqvist E. Loose stools lead to fecal incontinence among gynecological cancer survivors. Acta Oncol. 2011;50(2):233–42. 10.3109/0284186X.2010.535013
- Mansson A, Henningsohn L, Steineck G, Mansson W. Neutral third party versus treating institution for evaluating quality of life after radical cystectomy. European urology. 2004;46(2):195–9. 10.1016/j.eururo.2004.04.010
- Spearman C. General Intelligence, Objectively Determined and Measured. Am J Psychol. 1904;15 201–93.
- Choi J, Zou H, Oehlert G. A penalized maximum likelihood approach to sparse factor analysis. Stat Interface. 2010;3(4):429–36.
- Zientek LR, Thompson B. Applying the bootstrap to the multivariate case: bootstrap component/factor analysis. Behavior research methods. 2007;39(2):318–25.
- Efron B. Bootstrap methods: another look at the jackknife. Ann Stat. 1979;7(1):1–26.
- Buja A, Eyuboglu N. Remarks on Parallel Analysis. Multivariate behavioral research. 1992;27(4):509–40. 10.1207/s15327906mbr2704_2
- Kaiser HF. The Varimax Criterion for Analytic Rotation in Factor-Analysis. Psychometrika. 1958;23(3):187–200.
- Oh JH, Thor M, Olsson C, Skokic V, Jornsten R, Alsadius D, et al. A Factor Analysis Approach for Clustering Patient Reported Outcomes. Methods Inf Med. 2016;55(5).
Source: PubMed